{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "53"
        },
        "variant_string_id": "SNCA L53R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the a-synuclein (a-syn) gene are responsible for a rare familial parkinsonism syndrome.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as related to a-synuclein mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro studies of tau and a-syn fibrillization model the disease pathogenesis/mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays effectively model or reflect the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper lacks explicit statements on experimental repetition.",
          "judgment": "No",
          "reasoning": "Basic controls were used, but multiple replicates are not specified."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays (continued)",
          "extracted_paper_info": "The in vitro studies of tau and a-syn fibrillization are broadly accepted historically as standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The assays have been previously validated in other studies."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study includes variant controls that reach P/LP criteria, but does not explicitly state that statistical analyses were performed to estimate OddsPath.",
          "judgment": "No",
          "reasoning": "Insufficient data for Steps 4a and 4b."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation (continued)",
          "extracted_paper_info": "The final evidence strength is Max PS3_supporting / Max BS3_supporting.",
          "judgment": "Cannot be determined",
          "reasoning": "Insufficient data for sub-step 4b."
        }
      ],
      "final_evidence_strength": {
        "pathogenic": {
          "very_strong": "False",
          "moderate": "False",
          "supporting": "True"
        },
        "benign": {
          "very_strong": "False",
          "moderate": "False",
          "supporting": "False"
        }
      }
    }
  ]
}